Connect with us

Technology

Gabather reports initial positive results from the EEG/fMRI target engagement study

Published

on

STOCKHOLM, March 7, 2024 /PRNewswire/ — Gabather AB (Nasdaq First North Growth Market: GABA) today reports initial positive results from the EEG/fMRI target engagement study, a double-blinded placebo-controlled, cross-over phase Ib study of Gabather’s GABAA-receptor positive allosteric modulator, GT-002, in healthy volunteers.

The study met the primary objective to confirm a favourable safety and tolerability profile of GT-002. The secondary objective to demonstrate target engagement in human brain was also met. The study clearly demonstrated that GT-002 is safe and well tolerated at dose levels expected to be effective for treatment of patients with neuropsychiatric disorders.

Clinically relevant effects of GT-002 were observed on modulation of EEG frequency band power with a significant increase in alpha band power, compared to Lorazepam at the 2-hour after treatment. This effect spanned various brain regions, including frontal and occipital areas. No significant effect of Lorazepam on EEG alpha band power compared to placebo was observed. The results suggest a distinct effect of GT-002 to modulate alpha band power across specific cortical regions.

EEG alpha band power is recognized as a marker of cognitive activity such as attention and associated with relaxation and less anxiety, an increase in alpha band may be beneficial for a number of different neuropsychiatric conditions. Of particular clinical interest are the reports that negative symptoms in schizophrenia patients are associated with reduced EEG alpha band power.

“We have now proven clinically relevant target engagement in the human brain following oral administration of GT-002 showing that EEG and neuroimaging techniques can indeed open ‘a window into the brain’ and drive the drug development process of our candidate drugs. The next data to be presented will be a refined analysis of the EEG data during task performance and the fMRI neuroimaging data. With these results at hand, we will move forward into clinical trials in patients and identify the right partner for the continued development of GT-002,” says Michael-Robin Witt, CEO of Gabather AB.

 GT-002 Background

GT-002 is a small molecule GABAA receptor Positive Allosteric Modulator (PAM) eliciting both tonic and phasic inhibitory currents. GT-002 improves learning and memory in preclinical models. It restores ketamine induced cognitive deficits in the discrimination learning task model, and inhibits the behavioural effects induced by phencyclidine in the in-vivo model of schizophrenia. GT-002 has been shown to be anxiolytic and to promote social interaction in rats. GT-002 targets a novel binding site on GABAA receptors, different from benzodiazepines (BZD), and has not shown any of the side effects known for BZD. Long-term treatment (28 days) with GT-002 has not shown any withdrawal symptoms upon cessation of treatment both in mice and dogs, indicating no drug abuse liability associated with this drug candidate. GT-002 has successfully completed three phase I clinical trials in healthy volunteers. Both single ascending dose (SAD) and multiple ascending dose (MAD) studies have been completed. The results from these studies show that GT-002 is safe and well tolerated and that it has excellent pharmacokinetic properties, allowing for once-a-day oral dosing.

Contact Information

Michael-Robin Witt, CEO
Phone: 073-687 28 39
E-mail: mrw@gabather.com

About Gabather

Gabather is a clinical-stage pharmaceutical company aiming to transform the treatment of neuropsychiatric disorders. The Company was founded as a response to the significant unmet need and lack of innovative therapeutics in the mental health treatment landscape. Gabather is dedicated to developing innovative therapeutics for the treatment of a broad range of neuropsychiatric disorders. The goal is to accelerate the development of new groundbreaking medicines to achieve clinically meaningful therapies for the patients.

For more information, please visit: www.gabather.com

Certified Adviser

Corpura Fondkommission AB
Phone: +4672-252 34 51
Email: ca@corpura.se 
www.corpura.se

Forward-looking statement

This press release contains forward-looking statements that constitute subjective estimates and forecasts about the future. Assessments about the future are only valid on the date they are made and are, by their nature, similar to research and development work in the biotech field, associated with risk and uncertainty. In light of this, actual outcomes may differ substantially from what is described in this press release. Gabather is listed on First North Growth Market and Corpura Fondkommission AB is Certified Advisor.

The following files are available for download:

https://mb.cision.com/Public/11735/3942198/9693ab2d0c4c3557.pdf

PM positive clinical data GT-002 2024-03-07

 

View original content:https://www.prnewswire.co.uk/news-releases/gabather-reports-initial-positive-results-from-the-eegfmri-target-engagement-study-302082662.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MoonPay Invests in Korean Fintech Pioneer Finger, Laying Groundwork for a Korean Won Stablecoin Ecosystem

Published

on

By

The landmark ~$76M deal alongside Sungho Electronics and Pantos Holdings aims to connect MoonPay’s global crypto payments infrastructure with Finger’s domestic financial software network.

NEW YORK, April 22, 2026 /PRNewswire/ — MoonPay, the leading crypto payments network, KOSDAQ-listed Sungho Electronics, and its controlling shareholder Seoryong Electronics have signed an agreement to jointly invest in Finger, one of Korea’s first-generation fintech companies, in a deal that lays the foundation for a Korean won stablecoin ecosystem, from issuance to real-world usage.

Founded in 2000, Finger is a pioneering Korean fintech company whose technology powers the mobile banking apps used by tens of millions of Koreans daily. Its clients include Shinhan Bank, KB Kookmin Bank, KakaoBank, NongHyup Bank, and IBK Industrial Bank, among others. Its flagship service, “Full Banking,” is a financial platform solution covering account inquiry, transfers, payments, asset management, integrated account aggregation, and simple payment services. Its client base also includes public institutions such as the National Pension Service and the Korea Minting and Security Printing Corporation. Last year, the company recorded annual revenue of KRW 91.6 billion and operating profit of KRW 1.4 billion.

The approximately KRW 110 billion (~$76M) deal, also includes Pantos Holdings, a strategic investor wholly owned by Koo Bon-ho, a member of the LG founding family and former major shareholder of LX Pantos, the logistics arm of LX Group. The deal will combine MoonPay’s stablecoin issuance and orchestration infrastructure with Finger’s domestic financial software network, while linking Finger’s cloud ERP solution, “Pharos,” with MoonPay’s payments rails to commercialize stablecoin-based settlement for corporate trade payments.

Following the transaction, Seoryong Electronics will become Finger’s largest shareholder. Park Min-soo, the current vice chairman and controlling shareholder, will remain a key shareholder and serve in an advisory role to management.

Seoryong Electronics is the controlling shareholder of Sungho Electronics, with CEO Park Sung-jae holding a 100% stake in Seoryong Electronics. As Sungho Electronics has been focusing on business diversification through M&A, Seoryong Electronics has now also stepped forward directly to secure new growth engines through acquisitions.

Lee Bugeon, Founding Executive and Head of Asia at MoonPay, commented, “This investment opens the way to combine MoonPay’s stablecoin issuance and orchestration infrastructure with Finger’s domestic financial software network. It marks an important foothold for building the full infrastructure needed to support a Korean won stablecoin ecosystem, from issuance to real-world usage.”

Park Sung-jae, CEO of Sungho Electronics, said, “We will support the development of next-generation digital financial services for corporations by connecting ERP-based financial accounting data with payment infrastructure.”

About MoonPay
Founded in 2019, MoonPay is a global financial technology company that helps businesses and consumers move value across fiat and digital assets. MoonPay has more than 30 million customers across 180 countries and supports more than 500 enterprise customers spanning crypto and fintech.

MoonPay powers ramps, trading, commerce, and stablecoin infrastructure, connecting traditional payment rails with blockchains. MoonPay maintains a broad regulatory footprint, including a New York BitLicense, a New York Limited Purpose Trust Charter, and money transmitter licenses across the United States, as well as MiCA authorization in the EU.

MoonPay is how the world moves value.

For media enquiries, contact:
press@moonpay.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/moonpay-invests-in-korean-fintech-pioneer-finger-laying-groundwork-for-a-korean-won-stablecoin-ecosystem-302750964.html

SOURCE MoonPay

Continue Reading

Technology

Strong results achieved in world-first Graphene enhanced cement roof tile trial

Published

on

By

Highlights

Production trial of graphene enhanced roof tiles with FP McCann achieves CO2 reduction of up to 14%Project conducted in the United Kingdom also showed 26% reduction in CEM I-to-concrete ratio required to produce concrete roof tilesGraphene enhanced roof tiles to be used in new buildings at FP McCann’s Cadeby siteSuccessful results pave the way to enter US$7.6 billion[1] global cement roof tile market

SYDNEY, April 22, 2026 /PRNewswire/ — First Graphene Limited (ASX: FGR; “First Graphene” or “the Company”) (FRA:M11) (OTCQB:FGPHF) is pleased to announce results from a world-first production trial of graphene enhanced roof tiles with the UK’s largest precast concrete manufacturer and supplier FP McCann.

The five-month project used 40 tonnes of PureGRAPH® enhanced cement, developed by First Graphene’s partner Breedon Group, to produce more than 10,000 tiles at FP McCann’s Cadeby manufacturing facility in the UK.

The final graphene enhanced cement roof tiles were tested for quality, efficiency and carbon emission reduction potential, as well as performance consistency.

The production process achieved a cradle-to-gate reduction in carbon emissions of up to 14%, reinforcing the lower-carbon benefits of graphene for cement. The required amount of cement for the tiles was also reduced by up to 8%.

Importantly, the trial confirmed graphene enhanced cement, classified as CEM-II, could produce the same roof tiles at the same strength with fewer materials and lower costs compared to CEM-I.  

The tiles will be distributed for use in a variety of projects, including installation on a new building at FP McCann’s Cadeby site.

Conversations have commenced with industry partners following receipt of the results to determine interest in the graphene enhanced roof tiles for projects across the United Kingdom.

The UK Government has also committed to deliver more than one million affordable and sustainable new homes in the next three years and has been funding innovative construction solutions to achieve this goal.

This project was supported via ‘Contracts for Innovation’ with the UK Department for Energy Security and Net Zero (DESNZ) and the ‘Resource Efficient Construction Impacts’ program by the UK Department for Environment, Food and Rural Affairs’ (DEFRA).

The trial solidifies First Graphene’s entrance into the global cement roof tile market which is anticipated to grow to US$11.8 billion by 2034[1].

First Graphene Managing Director and CEO, Michael Bell, said:

“The results of this inaugural trial of graphene-enhanced cement roof tiles with FP McCann has reaffirmed the viability and performance benefits of a lower-emission cement product for the construction industry.

Reducing the amount of cement required by up to 20% has a significant impact on the carbon footprint of these roof tiles, paving the way for more sustainable houses and buildings.

As industry and governments look for innovative solutions to develop lower-carbon infrastructure, First Graphene and FP McCann, in partnership with Breedon Group, have a tested production blueprint to achieve emission reduction goals while maintaining or exceeding material performance capability.”

References

[1]Industry Research

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/strong-results-achieved-in-world-first-graphene-enhanced-cement-roof-tile-trial-302750112.html

SOURCE First Graphene Limited

Continue Reading

Technology

AKEEYO to Showcase 710 & 730 Series Cycling Cameras at Cycle Mode Tokyo 2026

Published

on

By

Full Lineup of Next-Generation Bike Cameras Available for Live Demo at East Hall 7, Booth 7-514

SHENZHEN, China, April 23, 2026 /PRNewswire/ — AKEEYO will exhibit at Cycle Mode Tokyo 2026 (April 25–26, Tokyo Big Sight, Booth 7-514 / East Hall 7), showcasing four cycling cameras with live demonstrations.

Exhibition Details

Event

Cycle Mode Tokyo 2026

Dates & Hours

Saturday, April 25, 2026: 10:00 – 18:00

Sunday, April 26, 2026: 10:00 – 17:00

Venue

Tokyo Big Sight, East Hall 7

Booth Number

7-514

Products on Display

AKY-730Pro  |  Flagship Bike Camera  |  US$200
Powered by an 8MP Sony IMX678 sensor (1/1.8″ Full @ 60FPS) with F/1.7 ultra-large aperture, 4K resolution, built-in GPS, 1.14″ touchscreen, EIS stabilization, IP66 waterproofing, and a 3300mAh battery delivering up to 6 hours of recording.

AKY-710Pro  |  Pro-Grade 8MP Bike Camera  |  US$139.99
Equipped with an 8MP GC8613 sensor (1/2.7″ Full @ 60FPS), F/1.6 aperture, 4K video, EIS gyro stabilization, dual-band Wi-Fi (2.4G/5G), and IP66 waterproofing. Built for demanding cyclists.

AKY-710S  |  Value Champion  |  US$99.99
5MP Sony STARVIS 2 IMX335 sensor with F/1.55 aperture, 142° ultra-wide angle lens, 4K (interpolated) video, HDR/WDR support, IP66 waterproofing, and 1800mAh battery for up to 4.5 hours of recording.

AKY-710Lite  |  Lightweight Entry Model  |  US$79.99
Weighing just 101g, the 710Lite delivers 2K recording at 28fps, F/2.0 aperture, 120° wide angle, IP66 waterproofing, and an impressive 7.5-hour battery life. Ideal for budget-conscious cyclists.

Why AKEEYO

Premium Sony & GC8613 sensors for exceptional image quality in all lighting conditionsIP66–IP67 waterproof and dustproof ratings for reliable performance in any weatherEIS electronic image stabilization for smooth, shake-free footage on the road

“Cycle Mode Tokyo 2026 is a landmark opportunity for AKEEYO to connect directly with Japan’s passionate riding community. We invite every cyclist and motorcyclist to visit our booth, test our cameras in person.”
— AKEEYO Marketing Team

Distributor & Dealer Opportunities

AKEEYO is actively seeking distributors and dealers worldwide. Visit our booth or reach out via the contact details below.

Website

www.akeeyo.com

Dealer Application

Application Form

About AKEEYO

AKEEYO specializes in smart recording solutions for motorcycles, bicycles, and vehicles — from pro-grade action cameras to intelligent dash cam systems. The brand serves markets across Asia, Europe, and the Americas through its global distributor network and e-commerce channels.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/akeeyo-to-showcase-710–730-series-cycling-cameras-at-cycle-mode-tokyo-2026-302750360.html

SOURCE AKEEYO

Continue Reading

Trending